Mutagenic radioadaptation in a human lymphoblastoid cell line.
We investigated the mutagenic radioadaptive response of human lymphoblastoid TK6 cells by pretreating them with a low dose (5 cGy) of X-rays followed by a high (2 Gy) dose 6h later. Pretreatment reduced the 2-Gy-induced mutation frequency (MF) of the thymidine kinase (TK) gene (18.3 x 10(-6)) to 62% of the original level (11.4 x 10(-6)). A loss of heterozygosity (LOH) detection analysis applied to the isolated TK(-) mutants revealed the mutational events as non-LOH (resulting mostly from a point mutation in the TK gene), hemizygous LOH (resulting from a chromosomal deletion), or homozygous LOH (resulting from homologous recombination (HR) between chromosomes). For non-LOH events, pretreatment decreased the frequency to 27% of the original level (from 7.1 x 10(-6) to 1.9 x 10(-6)). cDNAs prepared from the non-LOH mutants revealed that the decrease was due mainly to the repression of base substitutions. The frequency of hemizygous LOH events, however, was not significantly altered by pretreatment. Mapping analysis of chromosome 17 demonstrated that the distribution and the extent of hemizygous LOH events were also not significantly influenced by pretreatment. For homozygous LOH events, pretreatment reduced the frequency to 61% of the original level (from 5.1 x 10(-6) to 3.1 x 10(-6)), reflecting an enhancement in HR repair of DNA double-strand breaks. Our findings suggest that the radioadaptive response in TK6 cells follows mainly from mutations at the base-sequence level, not the chromosome level.
Yatagai
Fumio
F
Advanced Development and Support Center, The Institute of Physical and Chemical Research (RIKEN), Saitama 351-0198, Japan. yatagai@postman.riken.go.jp
Umebayashi
Yukihiro
Y
Honma
Masamitsu
M
Sugasawa
Kaoru
K
Takayama
Yuko
Y
Hanaoka
Fumio
F
D000220:Adaptation, Biological / Q000235:genetics*; D002460:Cell Line; D002470:Cell Survival; D002869:Chromosome Aberrations; D002886:Chromosomes, Human, Pair 17; D006801:Humans; D019656:Loss of Heterozygosity / Q000528:radiation effects*; D008214:Lymphocytes / Q000528:radiation effects*; D009152:Mutagenicity Tests; D009154:Mutation; D013937:Thymidine Kinase / Q000235:genetics*
D013937:Thymidine Kinase